SC
GILD icon

Sepio Capital’s Gilead Sciences GILD Stock Holding History

Sepio Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,656
Closed -$228K – 349
2022
Q4 		$228K Buy
+2,656
New +$210K 0.02% 313
2020
Q4 		– Sell
-3,700
Closed -$234K – 358
2020
Q3 		$234K Sell
3,700
-1,155
-24% -$80.1K 0.03% 318
2020
Q2 		$374K Sell
4,855
-4,600
-49% -$353K 0.04% 236
2020
Q1 		$707K Sell
9,455
-1,446
-13% -$99.9K 0.09% 144
2019
Q4 		$708K Sell
10,901
-168
-2% -$10.9K 0.07% 178
2019
Q3 		$707K Buy
11,069
+4,937
+81% +$323K 0.07% 173
2019
Q2 		$414K Sell
6,132
-1,832
-23% -$121K 0.06% 189
2019
Q1 		$524K Sell
7,964
-6,957
-47% -$462K 0.07% 180
2018
Q4 		$933K Buy
+14,921
New +$1.04M 0.07% 154

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sepio Capital's GILD Position: Q1 2023 in Review

Sepio Capital sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 2,656 shares — an estimated $228K sold.

Sepio Capital first reported a position in GILD in Q4 2018 and held it in 9 quarters. The position peaked at $933K in Q4 2018. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Sepio Capital reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Sepio Capital sold 2,656 Gilead Sciences shares in Q1 2023, an estimated $228K.
  • Sepio Capital first reported a position in Gilead Sciences in Q4 2018 and held it in 9 quarters.
  • Sepio Capital's Gilead Sciences position peaked at $933K in Q4 2018.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Sepio Capital's 13F filing for Q1 2023, filed 10 May 2023.